The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan.
Only 20% of people who are eligible for screening actually get checked. Some of this failure can be traced to persistent ...
U.S. President Donald Trump said on Friday the government is moving to make GLP-1 weight-loss and diabetes drugs ...
FinanceBuzz on MSN
Will Medicare cover Ozempic or Wegovy in 2026? What retirees need to know about GLP-1 coverage
Medicare may expand coverage for GLP-1 drugs like Wegovy in 2026. Learn who may qualify, what the program includes, and how ...
Medicare limits access to lifesaving treatments for common illnesses, including a type of heart valve disease affecting 2.5 ...
By Jim Miller Dear Savvy Senior, I’ll be 65 in a few months and could sure use some help sorting through all the confusing Medicare options that are available to me. Where can I get help with my ...
Health care policy researcher Nancy Keating discusses two new studies that suggest the short-lived experiment was more ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity ...
Most people reach their sixties with strong opinions about money, but one topic still blindsides even the most prepared ...
Expanding the GUIDE model’s eligibility language to include adults with intellectual and developmental disabilities offers a ...
The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in ...
DENVER — It's been months since President Trump signed an order declassifying marijuana. Now, a new pilot program is looking at the benefits of medicinal hemp. Experts said after the go-ahead from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results